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ABSTRACT
Sporotrichosis is a subcutaneous disease that affects both men and a variety of animals caused by the dimorphic
fungus Sporothrix schenckii. The aims of this study were to observe differences in virulence between inocula containing
the yeast (Y) or mycelial (M) forms, to compare the reactions induced by the two inocula injected in different anatomical
sites, and to verify the possibility of horizontal transmission of the disease by contact between infected and healthy
animals. All animals were observed during a period of nine weeks. Mice were inoculated subcutaneously in the paw pads
and in the regions of the hip and shoulder joints. Another group of non-inoculated healthy mice was kept in direct contact
with mice developing the subcutaneous lesions. Animals of groups Y and M developed lesions due to infections and
clinical symptoms very characteristic of sporothrichosis. Lesions were more prominent and with longer duration when
occurring in the pads than in any other site of inoculation. Non-inoculated mice remained healthy as it occurred to animals
in the control group. The development of typical clinical symptoms for sporothrichosis in all inoculated groups suggests
that no difference exists in virulence between the yeast and mycelial forms of the same isolated of S. schenckii. Moreover,
the paw pads appear to be the site of choice for the inoculation for experimental sporotrichosis in the murine model. In
addition, this study also showed that the contact with sick animals and contaminated materials is insufficient to transmit the
infection to immune competent animals with intact skin.
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RESUMO
A esporotricose é uma micose subcutânea causada pelo fungo dimórfico Sporothrix schenckii que acomete o
homem e uma grande variedade de animais. Este trabalho teve como objetivos verificar possíveis diferenças de virulência
entre inóculos das formas leveduriforme (Y) e filamentosa (M), comparar as reações induzidas pelos dois inóculos em
diferentes sítios anatômicos, além de verificar a possibilidade da ocorrência de transmissão de animais doentes para sadios.
Durante um período de nove semanas, foi observado o desenvolvimento da esporotricose experimental em camundongos
inoculados via subcutânea na almofadinha plantar e nas regiões das articulações escapuloumeral e coxofemural. Também,
camundongos não inoculados foram mantidos em contato direto com os que estavam desenvolvendo lesões subcutâneas.
Os animais dos grupos Y e M desenvolveram quadro clínico muito semelhante de esporotricose. Os inóculos provocaram
lesões mais evidentes e duradouras na almofadinha plantar do que nos outros sítios de inoculação. Os camundongos não
inoculados permaneceram hígidos à semelhança da situação observada no grupo controle. O desenvolvimento de quadro
clínico semelhante de esporotricose entre os grupos sugere que, a priori, não existam diferenças entre os inóculos das
formas leveduriforme e filamentosa de um mesmo isolado de S. schenckii. Os resultados também indicam que a almofadinha
plantar pode ser considerada como ponto de inoculação preferencial no modelo murino de esporotricose experimental, além
de comprovar que o simples contato de animais imunocompetentes, sem aparentes lesões de continuidade, com animais e
materiais contaminados não é suficiente para o desenvolvimento da esporotricose.
Descritores: Sporothrix schenckii, esporotricose experimental, forma leveduriforme, forma filamentosa, modelo murino,
camundongos.
162
Nobre M.O., Antunes T.A., Oliveira I.A., Berg V., Lucia Jr. T., Fernandes C.G., Meireles M.C.A. & Ferreiro L. Development of
experimental sporothrichosis in a murine model with yeast and mycelial... Acta Scientiae Veterinariae. 31: 161 - 166.
INTRODUCTION
Sporotrichosis is a subcutaneous mycosis that
has the dimorphic fungus Sporothrix schenckii as its
causative agent. The disease occurs in men (work-
related dermatosis) and in a great variety of animals
such as dogs, cats, horses, cattle, camels, goats, mules,
swine, rats, chimpanzee, birds and dolphins [4,5,7]. The
habitat of the fungus is soil rich in organic matter but it
grows in plants and tree bark in warm environments
with high humidity [4]. The dimorphic organism is
mycelial in the environment or in vitro in temperatures
inferior to 37°C and yeast-like in vivo or in vitro at
37°C [6].
With this work we aimed to verify possible
differences in the virulence between inocula of mycelial
and yeast forms of S. schenckii comparing the reactions
produced using three different sites of inoculation in mice.
Moreover, we tested the possibility of transmission of
this mycosis from affected animals to healthy ones.
MATERIALS AND METHODS
A thermostable isolate of Sporothrix
schenckii with pigmented conidia obtained from a
clinical case of feline cutaneous sporotrichosis was
used. Yeast inoculum was cultured in liquid medium
(Brain-Heart broth®) at 37ºC for 10 days and kept in a
shaker at 800 cycles per minute. Following this, cultures
were filtered in a double layer of sterile gauze,
centrifuged at 1500rpm for 15 minutes and washed
twice in PBS. Mycelial inoculum was cultured on 4%
Sabouraud’s dextrose-agar® in plates at 25ºC for 10
days. Mycelium was removed using a blade and
washed twice in PBS. It was filtered twice in a double
layer of sterile gauze and centrifuged at 1500rpm for
15 minutes.
Fifty-eight 7 weeks old-male-mice (Swiss
albino) were divided in three groups of 18 animals
each. Control group animals (group C) received PBS;
group Y mice were inoculated with the yeast form of
S. schenckii and, group M with the mycelial form of
the same isolate of the fungus. The left posterior paw
pad and the regions of right hip and right shoulder of
each inoculated mice received a subcutaneous injection
with 0.1mL of the suspension containing 2x103 cells
of S. schenckii/mL. And another two healthy mice
with intact skin were kept in direct contact with the
inoculated ones in each of the experimental groups.
Mice were observed daily for the development
of sporotrichosis during the nine following weeks. The
external diameter of the lesions in the sites of
inoculation were taken weekly with a sliding calliper
and the lesions size were used as a parameter to
estimate the clinical evolution of the disease.
Four necropsies were realized in the second,
forth, sixth and ninth weeks respectively to collect
samples from the inoculation sites and other areas when
dissemination of the mycosis was seen. Histopathology
and mycological tests were realized to identify the
organism S. schenckii with PAS method for the
histopathology and samples culture. Samples were
cultured in two plates containing Sabouraud’s dextrose
with chloramphenicol and cycloheximide (Bacto
mycobiotic agar®) at 25ºC and 37ºC during 10 days.
Statistics was made with Statistix 7.0 (Statistix,
2000) using frequency distribution of the diameter of
the lesions at sites of inoculation and clinical evolution
of the disease related to inocula with the yeast (Y)
and mycelial (M) form. Kruskal-Wallis method for
analysis of variance of non-parametric data was used
for differences between treatments due to the absence
of a normal distribution.
RESULTS
Animals of groups Y and M developed clinical
picture of sporotrichosis with similar clinical evolution.
A small swelling at the inoculation sites was noted in
24 hours following the inoculation in all animals
including the control group and that disappeared in 48
hours. First lesions were noted after the fifth day with
moderate edema and erythema of the paw pad that
became more severe on the sixth and seventh days.
At this time, mice showed an increased edema and
erythema and some cyanotic points in the paw pad
and had small nodules in the inoculated regions of the
hip and shoulder.
Lesions were more evident in the paw pads of
animals of both Y and M groups from the second until
the forth week with mice presenting ulcers, crusts,
necrosis and exudate with persistent edema and
erythema.
In relation to the different inocula, 50% of group
Y animals had necrosis with exudate in the second week
against 67% of group M animals. And this changed to
57% and 64% in the following week respectively for
the groups. In the forth week there was an evident
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reduction of lesions of group Y animals to 15% when
group M had 50% of the animals still presenting the
same clinical picture described above. In the fifth and
sixth weeks healing of lesions started to take place in
both groups. And in the eighth and ninth weeks 80% of
Y group mice and 20% of group M showed complete
remission of lesions in the paw pads.
Hip and shoulder regions showed ulcers, crusts
and necrosis between the second and the sixth week
with exudate until the fifth week. In the third week,
about 70% of group Y animals and 65% of group M
had exudate and in the fifth week 50% of group Y and
30% of group M were healing. A complete remission
of lesions in the hip and shoulder occurred in the seventh
week for both groups Y and M with those areas having
the same clinical aspect of the control group.
Moreover, both groups Y and M had cutaneous
lesions on the tail, testicles (Figure 1) and thighs between
weeks 4 and 6 following the inoculation what
characterized a picture of experimental sporotrichosis.
A total of two animals died of systemic sporotrichosis
during the course of the experiment being one animal of
each one of the inoculated groups (groups Y and M).
There were no significant differences (p>0.05)
in the average diameter of lesions between groups Y
and M. The average diameter of the intact skin in the
paw pads of all 58 studied animals was 1.2mm and
1.1mm for the regions of hips and shoulders what was
observed for the animals in control group during all
experimental period. In the first week the average
diameter of lesions in the paw pads for the two groups
was 3.4mm. In the second week the average values
reached their maximums of 4.2mm (Y) and 4.9mm
(M) that suffered a gradual decrease of 1.6mm and
2.2mm respectively until the ninth week. In the hip
and shoulder regions the diameters increased from the
second week and in the seventh week they returned
to the 1.1mm initial value (Figure 2). The alterations in
the paw pad were the first ones to appear and they
lasted until the end of the experiment (Figure 3).
Sporothrix schenckii was cultured from ma-
terial collected from the three first necropsies realized
in both groups. The fungus was found in the inoculation
sites and other regions of the skin that presented lesions
(thighs, testicles and tail) as well as from internal organs
(liver, spleen, mesenteric ganglions and lungs) of the
two animals with systemic sporotrichosis.
Histopathology alterations were more evident
in the samples of the first two necropsies with
granuloma presenting areas of necrosis having round or
elliptical yeast cells. Also, a great infiltration of
inflammatory cells with neutrophils, macrophages and
giant cells was found. Samples of the third necropsy
had less evident lesions corresponding to tissue repair
and the last necropsy material showed evident scar
reaction and isolation of the agent could no longer be
obtained.
The four not inoculated animals kept in the same
boxes with groups developing sporotrichosis (Y and M)
did not show any alterations in their healthy state from
the beginning to the end of the experimental period.
Figure 1. Mice inoculated with Sporothrix schenckii and showing disseminated sporotrichosis represented by lesions on
the testicles of a mouse inoculated with the yeast form (A) and lesions on the tail of another mouse inoculated with the
mycelial form (B).
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Figure 2. Average diameter of paw pad lesions observed for nine weeks in mice inoculated with the yeast form and mycelial
form of Sporothrix schenckii.
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Figure 3. Average lesion diameter of the three inoculation sites (paw pad, shoulder and hip regions) collected during nine
weeks in mice inoculated with the mycelial form of Sporothrix schenckii.
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DISCUSSION
Similarities between groups inoculated with
yeast and mycelial form of the fungus suggest that
both acquired infections caused by handling dirt and
plants [8,11] and feline injuries that usually have a great
amount of yeast cells of Sporothrix schenckii [7,9,15]
would potentially produce the same clinical picture.
Results obtained in this work support the hypothesis
that differences in clinical evolution of the disease would
be related to the individual pathogenicity of each
isolated and to the number of inoculated cells. It is
known that skin late hypersensitivity tests using S.
schenckii metabolic antigens extracted from yeast and
mycelial forms did not show differences [9].
Although there were not statistically significant
differences between groups Y and M, group M animals
had more severe clinical pictures that last longer than the
group Y animals. Results obtained allowed us to speculate
that pathogenicity factors such as the presence of melanin
(seeing in conidia used for group M) could have caused
some barriers to the host’s immune response. According
to what was previously demonstrated, the S. schenckii
conidia presence of DHN (dihydroxynaphthalene-
melanin) decreases murine monocytes and macrophages
phagocytic efficacy in vitro [14].
Furthermore it is important to consider that after
inoculation of the mycelial form of S. schenckii it will
occur a transition to the yeast form in the host beginning
with destruction of hyphae and conidia gradual
transformation to yeast cells [1]. During this transition
there is a period, not defined yet, in which melanin remains
in the fungal cell and it causes difficulties to the host’s
immune response what would make it easier for conidia
to survive and multiply. In the other hand, although yeast
cells could be initially more vulnerable to phagocytosis,
this form of the fungus presents other factors for
pathogenicity also responsible to trigger the infection.
Experimental sporotrichosis clinical develop-
ment and the observed histopathology alterations were
accordingly to other works [2,3,10,20]. However, scar
reaction observed in this experiment was more intense
in animals inoculated with the mycelial form (group
M) possibly due to the fact that the larger lesions could
have elicited a more intense epidermal and connective
tissue proliferation.
The paw pads already tested in other studies
[10,18] were considered the best site of inoculation
compared to hip and shoulder regions not previously
tested according to the literature reviewed. The
beginning of clinical signs occurred later in those new
regions of inoculation possibly due to the lack of
anatomic limits contributing to a smaller edema and to
a bigger diffusion of the inflammatory reaction.
The four not inoculated animals did not develop
sporotrichosis in spite of their permanent contact with
potential contamination sources represented by the
contact with infected animals, exudate and
contaminated tissue fragments. The maintenance of
the healthy state of those animals was favored by the
absence of continuity processes through their skin and
by their effective immune response.
There were classic examples of factor altering
the immune response related to sporotrichosis. Such
factors are stress, poor sanitary conditions and
immunosuppressive diseases in groups of feline where
several sporotrichosis cases were diagnosed during
three years [12,17]. Besides this, human sporotrichosis
has been linked to immunosuppressive diseases and
corticoid therapy [11,13,16].
CONCLUSIONS
The development of a similar sporotrichosis
clinical picture in both groups Y and M initially suggests
that there is no difference between inocula of yeast or
mycelial forms made from the same Sporothrix
schenckii isolate. Also, results imply that the paw pads
can be considered the preferential inoculation site in
the murine model for experimental sporotrichosis. And
it was demonstrated that contact with contaminated
animals and materials is not enough to cause
sporotrichosis in immunocompetent animals that have
no evidence of skin lesions.
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